(Reuters) – Dutch health technology company Philips on Monday said it had produced approximately 99% of the new replacement respiratory devices and repair kits required for the remediation of the registered affected devices.
Philips has been grappling with the fallout of a global recall of millions of respirators used to treat sleep apnoea since it was announced in June 2021.
The Amsterdam-based group also said litigation and investigation by the US Department of Justice related to the Respironics field action were ongoing, as well as the discussions on a proposed consent decree.
(Reporting by Diana Mandiá in Gdansk, editing by Kirsti Knolle)
